ADIPONECTIN - ANVISA Registration 10338930264
Access comprehensive regulatory information for ADIPONECTIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930264 and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including DEMEDITEC, IMMUNDIAGNOSTIK AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10338930264
25351218576202113
93741726000166
Company Information
Dates and Status
Sep 09, 2021
VIGENTE
09/18/2025 19:00:01
ADIPONECTIN
Adiponectin ELISA
DEMEDITEC
80464810513
Jul 31, 2017
ADIPONECTIN
Adiponectin (total) ELISA
IMMUNDIAGNOSTIK AG
80464810851
Sep 25, 2023
ADIPONECTIN
iFlash-Adiponectin
SHENZHEN YHLO BIOTECH CO., LTD.
80867150051
Dec 17, 2020
ADIPONECTIN
ADIPONECTIN CONTROL
Not specified
80867150111
Jul 22, 2021
LEPTIN
Leptina ELISA
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
10338930269
Sep 09, 2021
ADIPONECTINA
Adiponectin (total) ELISA
IMMUNDIAGNOSTIK AG
80464810851
Sep 25, 2023
ADIPONECTINA
ADIPONECTIN CONTROL
Not specified
80867150111
Jul 22, 2021
ADIPONECTINA
iFlash-Adiponectin
SHENZHEN YHLO BIOTECH CO., LTD.
80867150051
Dec 17, 2020
ADIPONECTINA
Adiponectina
EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
10338930197
Jan 14, 2019
ADIPONECTINA
Adiponectin ELISA
DEMEDITEC
80464810513
Jul 31, 2017